Wolff-Parkinson-White syndrome risk factors: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Risk Factors==
==Risk Factors==
High risk criteria for [[sudden cardiac death]] in [[Wolff-Parkinson-White syndrome]] during electrophysiology study include:<ref name="pmid22579340">{{cite journal |vauthors=Cohen MI, Triedman JK, Cannon BC, Davis AM, Drago F, Janousek J, Klein GJ, Law IH, Morady FJ, Paul T, Perry JC, Sanatani S, Tanel RE |title=PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS) |journal=Heart Rhythm |volume=9 |issue=6 |pages=1006–24 |date=June 2012 |pmid=22579340 |doi=10.1016/j.hrthm.2012.03.050 |url=}}</ref>
High risk criteria for [[sudden cardiac death]] in [[Wolff-Parkinson-White syndrome]] during electrophysiology study include:<ref name="pmid22579340">{{cite journal |vauthors=Cohen MI, Triedman JK, Cannon BC, Davis AM, Drago F, Janousek J, Klein GJ, Law IH, Morady FJ, Paul T, Perry JC, Sanatani S, Tanel RE |title=PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS) |journal=Heart Rhythm |volume=9 |issue=6 |pages=1006–24 |date=June 2012 |pmid=22579340 |doi=10.1016/j.hrthm.2012.03.050 |url=}}</ref><ref name="pmid492252">{{cite journal |vauthors=Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ |title=Ventricular fibrillation in the Wolff-Parkinson-White syndrome |journal=N. Engl. J. Med. |volume=301 |issue=20 |pages=1080–5 |date=November 1979 |pmid=492252 |doi=10.1056/NEJM197911153012003 |url=}}</ref>
* Presence of multiple accessory pathway
* Presence of multiple accessory pathway
* [[R-R interval]] <250 milliseconds in antegrade conduction of accessory pathway during inducing [[atrial fibrillation]]  
* [[R-R interval]] <250 milliseconds in antegrade conduction of accessory pathway during inducing [[atrial fibrillation]]  

Revision as of 08:07, 5 September 2020

Wolff-Parkinson-White syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Wolff-Parkinson-White syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Approach

History and Symptoms

Electrocardiogram

EKG Examples

Other Diagnostic Studies

Treatment

Risk Stratification

Cardioversion

Medical Therapy

Catheter Ablation

Prophylaxis

Consensus Statement

Case Studies

Case #1

Wolff-Parkinson-White syndrome risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wolff-Parkinson-White syndrome risk factors

CDC onWolff-Parkinson-White syndrome risk factors

Wolff-Parkinson-White syndrome risk factors in the news

Blogs on Wolff-Parkinson-White syndrome risk factors

Directions to Hospitals Treating Deep vein thrombosis

Risk calculators and risk factors for Wolff-Parkinson-White syndrome risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Risk Factors

High risk criteria for sudden cardiac death in Wolff-Parkinson-White syndrome during electrophysiology study include:[1][2]





  • Policemen
  • Athletes
  • Firemen
  • Pilots
  • Steelworkers

Risk factors for the development of atrial fibrillation in WPW syndrome include[3]:

  • Male gender
  • Age (peak ages for the development of atrial fibrillation include 30 years and 50 years)
  • Past history of syncope

References

  1. Cohen MI, Triedman JK, Cannon BC, Davis AM, Drago F, Janousek J, Klein GJ, Law IH, Morady FJ, Paul T, Perry JC, Sanatani S, Tanel RE (June 2012). "PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS)". Heart Rhythm. 9 (6): 1006–24. doi:10.1016/j.hrthm.2012.03.050. PMID 22579340.
  2. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ (November 1979). "Ventricular fibrillation in the Wolff-Parkinson-White syndrome". N. Engl. J. Med. 301 (20): 1080–5. doi:10.1056/NEJM197911153012003. PMID 492252.
  3. Fengler BT, Brady WJ, Plautz CU (2007). "Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED". Am J Emerg Med. 25 (5): 576–83. doi:10.1016/j.ajem.2006.10.017. PMID 17543664. Unknown parameter |month= ignored (help)

Template:WH Template:WS